A survey of thousands of people in England suggests it may be time to look again at how pharma manufacturers are delivering product information to patients.
It’s evident that relying on Google for a health diagnosis isn’t a good idea, but it seems a majority of UK people still do – and even buy medicines based on what they find.
The NHS has responded to criticism of its policy of sharing patients’ names and addresses with immigration officials, citing a survey showing that the majority of the public support it.
As the ASCO congress drew to a close, Johnson & Johnson filed for FDA approval of its BCMA-targeting CAR-T therapy Carvykti for use earlier in the treatment pathway fo
Health systems globally have reached a critical inflexion point, where ageing populations and tightening budgets mean we can no longer continue to purely treat late-stage symptomatic diseas